KRAS and breast cancer: The collective observations on the EF1-tTA-mediated, transgenic expression model, and mammary tumors that express oncogenic KRAS from the endogenous locus suggested that RAS signaling is a determinant for the genesis of basal-like and claudin-low molecular subtypes.